Table 1.
Neuroblastoma cell line information.
| Cell Line | Organism | Cancer Histology | Matched PDX | MYCN Status | Growth Media | Detachment Method |
|---|---|---|---|---|---|---|
| COG-N-415 | Homo sapiens | Neuroblastoma | COG-N-415x | Amplified | IMDM, 20% FBS, 2 mM L-glutamine, 1:1000 ITS Premix Supplement | 0.02% Versene |
| KELLY | Homo sapiens | Neuroblastoma | N/A | Amplified | RPMI 1640, 10% FBS, 1% Penicillin/Streptomycin, 2 mM L-Glutamine | 0.02% Versene |
| LA-N-5 | Homo sapiens | Neuroblastoma | N/A | Amplified | RPMI 1640, 10% FBS, 1% Penicillin/Streptomycin, 2 mM L-Glutamine | 0.02% Versene |
| NB-1643 | Homo sapiens | Neuroblastoma | NB-1643 | Amplified | IMDM, 20% FBS, 1% Penicillin/Streptomycin, 2 mM L-glutamine | 0.02% Versene |
| NB-69 | Homo sapiens | Neuroblastoma | N/A | Non-Amplified | RPMI 1640, 10% FBS, 1% Penicillin/Streptomycin, 2 mM L-Glutamine | 0.02% Versene |
| NB-LS | Homo sapiens | Neuroblastoma | N/A | Non-Amplified | RPMI 1640, 10% FBS, 1% Penicillin/Streptomycin, 2 mM L-Glutamine | 0.02% Versene |
| NGP | Homo sapiens | Neuroblastoma | N/A | Amplified | RPMI 1640, 10% FBS, 1% Penicillin/Streptomycin, 2 mM L-Glutamine | 0.02% Versene |
| SK-N-AS | Homo sapiens | Neuroblastoma | SK-N-AS (xenograft) | Non-Amplified | RPMI 1640, 10% FBS, 1% Penicillin/Streptomycin, 2 mM L-Glutamine | 0.05% Trypsin/EDTA |
| SK-N-BE(2)-C | Homo sapiens | Neuroblastoma | N/A | Amplified | RPMI 1640, 10% FBS, 1% Penicillin/Streptomycin, 2 mM L-Glutamine | 0.02% Versene |
| SK-N-FI | Homo sapiens | Neuroblastoma | N/A | Non-Amplified | RPMI 1640, 10% FBS, 1% Penicillin/Streptomycin, 2 mM L-Glutamine | 0.02% Versene |
| SK-N-SH | Homo sapiens | Neuroblastoma | N/A | Non-Amplified | RPMI 1640, 10% FBS, 1% Penicillin/Streptomycin, 2 mM L-Glutamine | 0.05% Trypsin/EDTA |
Listed are the cell lines used in this study, their MYCN amplification status, and culturing media information.